Panome Bio Board Member Appointed Mosaic Biosciences Chief Executive Officer
St. Louis, MO, October 7, 2025 – Panome Bio, a leader in next-generation metabolomics and proteomics, today congratulated Board member Jean Pierre (“JP”) Wery, PhD, on his appointment as Chief Executive Officer of Mosaic Biosciences, a comprehensive biologics discovery company accelerating antibody discovery, protein engineering, and the development of next-generation biologics.
Dr. Wery brings more than two decades of leadership experience in the biotechnology and pharmaceutical industries, with a proven record of building high-growth organizations, guiding scientific strategy, and advancing translational research. His appointment underscores Mosaic’s commitment to accelerating innovation in biologics discovery and development.
In addition to his role at Mosaic, Dr. Wery serves on Panome Bio’s Advisory Board, where he contributes strategic guidance on applying advanced multi-omics technologies to complex biological and clinical research challenges.
Prior to joining Mosaic, Dr. Wery held senior leadership roles at Eli Lilly, Vitae Pharmaceuticals, Monarch Life Sciences, Crown Bioscience, and Sidewinder Therapeutics. He co-founded Crown Bioscience and served as its Chief Executive Officer, leading the company’s growth into a global leader in preclinical oncology services. Most recently, he was the founder and CEO of Sidewinder Therapeutics, advancing precision antibody-drug conjugate (ADC) therapeutics.
Panome Bio congratulates Dr. Wery on this appointment and looks forward to his continued contributions to advancing multi-omics applications in biomedical discovery and therapeutic innovation.